Restoring vision by replacing damaged retinal cells in glaucoma
Overcoming Barriers to retinal ganglion cell replacement in experimental glaucoma
This study is exploring how to replace damaged cells in the eyes of people with glaucoma to help restore their vision, using special stem cells and advanced techniques to overcome challenges in the process.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10925294 on NIH RePORTER |
What this research studies
This research focuses on replacing damaged retinal ganglion cells (RGCs) in patients suffering from glaucoma, a condition that can lead to blindness. The team uses a well-established experimental model to study RGC degeneration and has already shown success in transplanting stem cell-derived RGCs into the retina. By identifying and addressing barriers to effective cell replacement, the researchers aim to develop strategies that could restore vision in individuals affected by glaucoma and other optic neuropathies. The approach combines advanced cell manipulation techniques with a thorough understanding of the underlying biology of the disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with glaucoma or other optic neuropathies who are experiencing vision loss.
Not a fit: Patients with conditions unrelated to retinal ganglion cell damage or those who are not experiencing vision impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that restore vision for patients with glaucoma-related blindness.
How similar studies have performed: Other research has shown promise in similar approaches to cell replacement therapy, indicating potential for success in this area.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Meyer, Jason Stephen — Indiana University Indianapolis
- Study coordinator: Meyer, Jason Stephen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.